Abbott (NYSE: ABT) reported Q4 EPS of $0.65, in-line with the analyst estimate of $0.65. Revenue for the quarter came in at $5.33 billion versus the consensus estimate of $5.38 billion.

GUIDANCE:

Abbott sees FY2017 EPS of $2.40-$2.50, versus the consensus of $2.45.

For earnings history and earnings-related data on Abbott (ABT) click here.